134 related articles for article (PubMed ID: 12389495)
1. [Causes of recurrence of patients with chromaffin tumors].
Bel'tsevich DG; Kuznetsov NS
Khirurgiia (Mosk); 2002; (8):19-23. PubMed ID: 12389495
[TBL] [Abstract][Full Text] [Related]
2. Granins and their derived peptides in normal and tumoral chromaffin tissue: Implications for the diagnosis and prognosis of pheochromocytoma.
Guérin M; Guillemot J; Thouënnon E; Pierre A; El-Yamani FZ; Montero-Hadjadje M; Dubessy C; Magoul R; Lihrmann I; Anouar Y; Yon L
Regul Pept; 2010 Nov; 165(1):21-9. PubMed ID: 20600356
[TBL] [Abstract][Full Text] [Related]
3. S100 protein-positive sustentacular cells in malignant and locally aggressive adrenal pheochromocytomas.
Unger P; Hoffman K; Pertsemlidis D; Thung S; Wolfe D; Kaneko M
Arch Pathol Lab Med; 1991 May; 115(5):484-7. PubMed ID: 1673596
[TBL] [Abstract][Full Text] [Related]
4. [Recurrent pheochromocytoma].
Sun Z; Wang Y; Li Z
Zhonghua Wai Ke Za Zhi; 1998 Jan; 36(1):59-60. PubMed ID: 11715546
[TBL] [Abstract][Full Text] [Related]
5. KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma.
Elder EE; Xu D; Höög A; Enberg U; Hou M; Pisa P; Gruber A; Larsson C; Bäckdahl M
Mod Pathol; 2003 Mar; 16(3):246-55. PubMed ID: 12640105
[TBL] [Abstract][Full Text] [Related]
6. Oncologic aspects of pheochromocytoma: the importance of follow-up.
Scott HW; Halter SA
Surgery; 1984 Dec; 96(6):1061-6. PubMed ID: 6505959
[TBL] [Abstract][Full Text] [Related]
7. [Tumors of chromaffin tissue (symptoms, diagnosis, surgical treatment)].
Vetshev PS; Simonenko VB; Ippolitov LI; Skliar AN; Dulin PA; Golysheva SV
Khirurgiia (Mosk); 2002; (8):11-8. PubMed ID: 12389494
[TBL] [Abstract][Full Text] [Related]
8. [Personal experience in diagnosis and localization of pheochromocytoma].
Andjelković Z; Tavcar I
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():14-9. PubMed ID: 12584992
[TBL] [Abstract][Full Text] [Related]
9. [Pheochromocytoma--pathohistologic and immunohistochemical aspects].
Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991
[TBL] [Abstract][Full Text] [Related]
10. 1,111 patients with adrenal incidentalomas observed at a single endocrinological center: incidence of chromaffin tumors.
Kasperlik-Zaluska AA; Roslonowska E; Slowinska-Srzednicka J; Otto M; Cichocki A; Cwikla J; Slapa R; Eisenhofer G
Ann N Y Acad Sci; 2006 Aug; 1073():38-46. PubMed ID: 17102070
[TBL] [Abstract][Full Text] [Related]
11. [Pheochromocytoma and sympathetic paragangliomas].
Zollinger R; Hedinger C
Schweiz Med Wochenschr; 1983 Jul; 113(30):1057-65. PubMed ID: 6623024
[TBL] [Abstract][Full Text] [Related]
12. Changes in urinary total metanephrine excretion in recurrent and malignant pheochromocytomas and secreting paragangliomas.
Amar L; Peyrard S; Rossignol P; Zinzindohoue F; Gimenez-Roqueplo AP; Plouin PF
Ann N Y Acad Sci; 2006 Aug; 1073():383-91. PubMed ID: 17102107
[TBL] [Abstract][Full Text] [Related]
13. Expression of connexins in chromaffin cells of normal human adrenals and in benign and malignant pheochromocytomas.
Willenberg HS; Schott M; Saeger W; Tries A; Scherbaum WA; Bornstein SR
Ann N Y Acad Sci; 2006 Aug; 1073():578-83. PubMed ID: 17102126
[TBL] [Abstract][Full Text] [Related]
14. [Endocrine arterial hypertension. Pheochromocytoma].
Telles EC; Machado FS; Bicho MP; Rego F; Almeida G; Amram S
Acta Med Port; 1989; 2(1):41-5. PubMed ID: 2672701
[TBL] [Abstract][Full Text] [Related]
15. Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC-associated factor X.
Qin N; de Cubas AA; Garcia-Martin R; Richter S; Peitzsch M; Menschikowski M; Lenders JW; Timmers HJ; Mannelli M; Opocher G; Economopoulou M; Siegert G; Chavakis T; Pacak K; Robledo M; Eisenhofer G
Int J Cancer; 2014 Nov; 135(9):2054-64. PubMed ID: 24676840
[TBL] [Abstract][Full Text] [Related]
16. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
17. Survivin: a novel neuroendocrine marker for pheochromocytoma.
Koch CA; Vortmeyer AO; Diallo R; Poremba C; Giordano TJ; Sanders D; Bornstein SR; Chrousos GP; Pacak K
Eur J Endocrinol; 2002 Mar; 146(3):381-8. PubMed ID: 11888845
[TBL] [Abstract][Full Text] [Related]
18. Recurrent operated malignant pheochromocytoma.
Marinescu I; Stefănescu AM
Endocrinologie; 1985; 23(1):61-6. PubMed ID: 3992158
[TBL] [Abstract][Full Text] [Related]
19. Malignancy in pheochromocytomas.
Salmenkivi K; Heikkilä P; Haglund C; Arola J
APMIS; 2004 Sep; 112(9):551-9. PubMed ID: 15601303
[TBL] [Abstract][Full Text] [Related]
20. [Malignant pheochromocytoma. A case report in a 10-year-old boy with vertebral metastasis].
Galifer RB; Pous JG; Noblet D
Chir Pediatr; 1982; 23(2):121-4. PubMed ID: 7074719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
